Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

PurposeIn the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial, patients with 1 or 2 tumour-involved sentinel lymph nodes (SLNs) gained no benefit from completion axillary lymph dissection (cALND). We examined implementation of evidence from this trial into routine clinical managemen...

Full description

Saved in:
Bibliographic Details
Main Authors: Hennigs, André (Author) , Köpke, Melitta (Author) , Feißt, Manuel (Author) , Riedel, Fabian (Author) , Rezai, Mahdi (Author) , Nitz, Ulrike (Author) , Moderow, Mareike (Author) , Golatta, Michael (Author) , Sohn, Christof (Author) , Schneeweiss, Andreas (Author) , Heil, Jörg (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: Breast cancer research and treatment
Year: 2019, Volume: 173, Issue: 2, Pages: 429-438
ISSN:1573-7217
DOI:10.1007/s10549-018-5009-2
Online Access:Verlag, Volltext: https://doi.org/10.1007/s10549-018-5009-2
Get full text
Author Notes:André Hennigs, Melitta Köpke, Manuel Feißt, Fabian Riedel, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Andreas Schneeweiss, Jörg Heil

MARC

LEADER 00000caa a2200000 c 4500
001 1668044331
003 DE-627
005 20220816175553.0
007 cr uuu---uuuuu
008 190627s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10549-018-5009-2  |2 doi 
035 |a (DE-627)1668044331 
035 |a (DE-599)KXP1668044331 
035 |a (OCoLC)1341230358 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hennigs, André  |e VerfasserIn  |0 (DE-588)1077795238  |0 (DE-627)837512395  |0 (DE-576)446682780  |4 aut 
245 1 0 |a Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?  |c André Hennigs, Melitta Köpke, Manuel Feißt, Fabian Riedel, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Andreas Schneeweiss, Jörg Heil 
264 1 |c 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 12 October 2018 
500 |a Gesehen am 27.06.2019 
520 |a PurposeIn the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial, patients with 1 or 2 tumour-involved sentinel lymph nodes (SLNs) gained no benefit from completion axillary lymph dissection (cALND). We examined implementation of evidence from this trial into routine clinical management.MethodsData were included from patients diagnosed with primary breast cancer in German breast cancer units between 2008 and 2015 and analysed retrospectively from a prospective maintained database. Descriptive analyses assessed time-trend changes in axillary surgery. Factors associated with cALND in patients with 1 or 2 positive SLNs were identified using multivariable logistic regression analysis.ResultsOverall, 179 breast cancer units provided data for 188,909 patients, of whom 13,741 (7.3%) had pT1/2cN0M0 invasive breast cancer with 1 or 2 tumour-involved SLNs and underwent breast-conserving surgery and adjuvant radiotherapy. cALND use decreased from 94.6% in 2008 to 46.9% in 2015 (p < 0.001). In multivariable analyses, the following factors were associated with cALND: fewer removed SLNs; two tumour-affected SLNs; younger age; lower annual case volume per hospital; higher tumour grade and lymphovascular invasion. No statistically significant influence was detected for hormone receptor or HER2 status.ConclusionIn our cohort, 7.3% of patients with primary breast cancer met the ACOSOG Z0011 inclusion criteria and could potentially have been spared the morbidity of cALND. cALND tended to be performed in patients with a higher axillary tumour burden. This study shows a shift towards less extensive axillary surgery through rapid implementation of new clinical trial evidence into routine clinical practice. 
650 4 |a ACOSOG Z0011 
650 4 |a Axillary lymph node dissection 
650 4 |a Breast cancer 
650 4 |a Mastectomy 
650 4 |a Sentinel lymph node dissection 
650 4 |a Time-tend analysis 
650 4 |a Tumour-involved sentinel lymph node 
700 1 |a Köpke, Melitta  |d 1995-  |e VerfasserIn  |0 (DE-588)1234108801  |0 (DE-627)1758981482  |4 aut 
700 1 |a Feißt, Manuel  |d 1989-  |e VerfasserIn  |0 (DE-588)1158520948  |0 (DE-627)1020533544  |0 (DE-576)504012312  |4 aut 
700 1 |a Riedel, Fabian  |d 1987-  |e VerfasserIn  |0 (DE-588)1117048381  |0 (DE-627)870923951  |0 (DE-576)478697007  |4 aut 
700 1 |a Rezai, Mahdi  |d 1953-  |e VerfasserIn  |0 (DE-588)1107970350  |0 (DE-627)863713580  |0 (DE-576)475152131  |4 aut 
700 1 |a Nitz, Ulrike  |e VerfasserIn  |4 aut 
700 1 |a Moderow, Mareike  |e VerfasserIn  |4 aut 
700 1 |a Golatta, Michael  |d 1974-  |e VerfasserIn  |0 (DE-588)132350386  |0 (DE-627)521535727  |0 (DE-576)299091392  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Heil, Jörg  |d 1978-  |e VerfasserIn  |0 (DE-588)132580187  |0 (DE-627)52396160X  |0 (DE-576)299238679  |4 aut 
773 0 8 |i Enthalten in  |t Breast cancer research and treatment  |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981  |g 173(2019), 2, Seite 429-438  |h Online-Ressource  |w (DE-627)320433722  |w (DE-600)2004077-5  |w (DE-576)104194162  |x 1573-7217  |7 nnas  |a Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice? 
773 1 8 |g volume:173  |g year:2019  |g number:2  |g pages:429-438  |g extent:10  |a Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice? 
856 4 0 |u https://doi.org/10.1007/s10549-018-5009-2  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190627 
993 |a Article 
994 |a 2019 
998 |g 132580187  |a Heil, Jörg  |m 132580187:Heil, Jörg  |d 910000  |d 910400  |e 910000PH132580187  |e 910400PH132580187  |k 0/910000/  |k 1/910000/910400/  |p 11  |y j 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 10 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 9 
998 |g 132350386  |a Golatta, Michael  |m 132350386:Golatta, Michael  |d 910000  |d 910400  |e 910000PG132350386  |e 910400PG132350386  |k 0/910000/  |k 1/910000/910400/  |p 8 
998 |g 1117048381  |a Riedel, Fabian  |m 1117048381:Riedel, Fabian  |d 910000  |d 910400  |e 910000PR1117048381  |e 910400PR1117048381  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 1158520948  |a Feißt, Manuel  |m 1158520948:Feißt, Manuel  |d 910000  |d 999701  |e 910000PF1158520948  |e 999701PF1158520948  |k 0/910000/  |k 1/910000/999701/  |p 3 
998 |g 1234108801  |a Köpke, Melitta  |m 1234108801:Köpke, Melitta  |d 50000  |e 50000PK1234108801  |k 0/50000/  |p 2 
998 |g 1077795238  |a Hennigs, André  |m 1077795238:Hennigs, André  |d 910000  |d 910400  |e 910000PH1077795238  |e 910400PH1077795238  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1668044331  |e 3490014405 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1668044331","relHost":[{"recId":"320433722","pubHistory":["1.1981 -"],"origin":[{"publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1981","dateIssuedDisp":"1981-","publisher":"Springer Science + Business Media B.V. ; Kluwer"}],"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"id":{"issn":["1573-7217"],"zdb":["2004077-5"],"eki":["320433722"]},"language":["eng"],"disp":"Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?Breast cancer research and treatment","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Breast cancer research and treatment","title":"Breast cancer research and treatment"}],"part":{"year":"2019","pages":"429-438","text":"173(2019), 2, Seite 429-438","volume":"173","extent":"10","issue":"2"},"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"note":["First online: 12 October 2018","Gesehen am 27.06.2019"],"person":[{"family":"Hennigs","role":"aut","given":"André","display":"Hennigs, André"},{"family":"Köpke","given":"Melitta","display":"Köpke, Melitta","role":"aut"},{"family":"Feißt","role":"aut","given":"Manuel","display":"Feißt, Manuel"},{"role":"aut","display":"Riedel, Fabian","given":"Fabian","family":"Riedel"},{"given":"Mahdi","display":"Rezai, Mahdi","role":"aut","family":"Rezai"},{"role":"aut","given":"Ulrike","display":"Nitz, Ulrike","family":"Nitz"},{"family":"Moderow","given":"Mareike","display":"Moderow, Mareike","role":"aut"},{"family":"Golatta","display":"Golatta, Michael","given":"Michael","role":"aut"},{"role":"aut","display":"Sohn, Christof","given":"Christof","family":"Sohn"},{"given":"Andreas","display":"Schneeweiss, Andreas","role":"aut","family":"Schneeweiss"},{"role":"aut","given":"Jörg","display":"Heil, Jörg","family":"Heil"}],"title":[{"title_sort":"Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?","title":"Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?"}],"physDesc":[{"extent":"10 S."}],"id":{"eki":["1668044331"],"doi":["10.1007/s10549-018-5009-2"]},"name":{"displayForm":["André Hennigs, Melitta Köpke, Manuel Feißt, Fabian Riedel, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Andreas Schneeweiss, Jörg Heil"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a HENNIGSANDWHICHPATIE2019